|
1
|
Broaddus E, Topham A and Singh AD:
Incidence of retinoblastoma in the USA: 1975–2004. Br J Ophthalmol.
93:21–23. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Zheng C, Schneider JW and Hsieh J: Role of
RB1 in human embryonic stem cell-derived retinal organoids. Dev
Biol. 462:197–207. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Hu H, Zhang W, Wang Y, Huang D, Shi J, Li
B, Zhang Y and Zhou Y: Characterization, treatment and prognosis of
retinoblastoma with central nervous system metastasis. BMC
Ophthalmol. 18:1072018. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Berry JL, Kogachi K, Aziz HA, McGovern K,
Zolfaghari E, Murphree AL, Jubran R and Kim JW: Risk of metastasis
and orbital recurrence in advanced retinoblastoma eyes treated with
systemic chemoreduction versus primary enucleation. Pediatr Blood
Cancer. 64:102017. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Chawla B and Singh R: Recent advances and
challenges in the management of retinoblastoma. Indian J
Ophthalmol. 65:133–139. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Perkel JM: Visiting ‘noncodarnia’.
Biotechniques. 54:301, 303–304. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Fang Y and Fullwood MJ: Roles, functions,
and mechanisms of long Non-coding RNAs in cancer. Genomics
Proteomics Bioinformatics. 14:42–54. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Kopp F and Mendell JT: Functional
classification and experimental dissection of long noncoding RNAs.
Cell. 172:393–407. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Zhao W, Ma X, Liu L, Chen Q, Liu Z, Zhang
Z, Ma S, Wang Z, Li H, Wang Z and Wu J: SNHG20: A vital lncRNA in
multiple human cancers. J Cell Physiol. 2019.(Epub ahead of
print).
|
|
10
|
Wang ZX, Zhao Y, Yu Y, Liu N, Zou QX,
Liang FH, Cheng KP and Lin FW: Effects of lncRNA SNHG20 on
proliferation and apoptosis of non-small cell lung cancer cells
through Wnt/β-catenin signaling pathway. Eur Rev Med Pharmacol Sci.
24:230–237. 2020.PubMed/NCBI
|
|
11
|
Wu X, Xiao Y, Zhou Y, Zhou Z and Yan W:
lncRNA SNHG20 promotes prostate cancer migration and invasion via
targeting the miR-6516-5p/SCGB2A1 axis. Am J Transl Res.
11:5162–5169. 2019.PubMed/NCBI
|
|
12
|
Yu J, Shen J, Qiao X, Cao L, Yang Z, Ye H,
Xi C, Zhou Q, Wang P and Gong Z: SNHG20/miR-140-5p/NDRG3 axis
contributes to 5-fluorouracil resistance in gastric cancer. Oncol
Lett. 18:1337–1343. 2019.PubMed/NCBI
|
|
13
|
Liu J, Cheng LG and Li HG: LncRNA SNHG20
promoted the proliferation of glioma cells via sponging miR-4486 to
regulate the MDM2-p53 pathway. Eur Rev Med Pharmacol Sci.
23:5323–5331. 2019.PubMed/NCBI
|
|
14
|
Wang D, Dai J, Hou S and Qian Y: LncRNA
SNHG20 predicts a poor prognosis and promotes cell progression in
epithelial ovarian cancer. Biosci Rep. 39:BSR201821862019.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Zeng J, Liu Z, Zhang C, Hong T, Zeng F,
Guan J, Tang S and Hu Z: Prognostic value of long non-coding RNA
SNHG20 in cancer: A meta-analysis. Medicine (Baltimore).
99:e192042020. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Paraskevopoulou MD and Hatzigeorgiou AG:
Analyzing MiRNA-LncRNA Interactions. Methods Mol Biol.
1402:271–286. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Huang YA, Huang ZA, You ZH, Zhu Z, Huang
WZ, Guo JX and Yu CQ: Predicting lncRNA-miRNA interaction via graph
convolution Auto-Encoder. Front Genet. 10:7582019. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Du W, Tang H, Lei Z, Zhu J, Zeng Y, Liu Z
and Huang JA: MiR-335-5p inhibits TGF-β1-induced
epithelial-mesenchymal transition in non-small cell lung cancer via
ROCK1. Respir Res. 20:2252019. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Zhang D and Yang N: MiR-335-5p inhibits
cell proliferation, migration and invasion in colorectal cancer
through downregulating LDHB. J BUON. 24:1128–1136. 2019.PubMed/NCBI
|
|
20
|
Luo L, Xia L, Zha B, Zuo C, Deng D, Chen
M, Hu L, He Y, Dai F, Wu J, et al: miR-335-5p targeting ICAM-1
inhibits invasion and metastasis of thyroid cancer cells. Biomed
Pharmacother. 106:983–990. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Gao Y, Li H, Ma X, Fan Y, Ni D, Zhang Y,
Huang Q, Liu K, Li X, Wang L, et al: E2F3 upregulation promotes
tumor malignancy through the transcriptional activation of HIF-2α
in clear cell renal cell carcinoma. Oncotarget. 8:54021–54036.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Feng Z, Peng C, Li D, Zhang D, Li X, Cui
F, Chen Y and He Q: E2F3 promotes cancer growth and is
overexpressed through copy number variation in human melanoma. Onco
Targets Ther. 11:5303–5313. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Zhao W, Wang S, Qin T and Wang W: Circular
RNA (circ-0075804) promotes the proliferation of retinoblastoma via
combining heterogeneous nuclear ribonucleoprotein K (HNRNPK) to
improve the stability of E2F transcription factor 3 E2F3. J Cell
Biochem. 121:3516–3525. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) Method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Carlevaro-Fita J, Lanzos A, Feuerbach L,
Hong C, Mas-Ponte D, Pedersen JS; PCAWG Drivers and Functional
Interpretation Group, ; Johnson R; PCAWG Consortium, : Cancer
LncRNA Census reveals evidence for deep functional conservation of
long noncoding RNAs in tumorigenesis. Commun Biol. 3:562020.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Plousiou M and Vannini I: Non-Coding RNAs
in Retinoblastoma. Front Genet. 10:11552019. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Yu Y, Gao R, Kaul Z, Li L, Kato Y, Zhang
Z, Groden J, Kaul SC and Wadhwa R: Loss-of-function screening to
identify miRNAs involved in senescence: Tumor suppressor activity
of miRNA-335 and its new target CARF. Sci Rep. 6:301852016.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Sandoval-Borquez A, Polakovicova I,
Carrasco-Veliz N, Lobos-González L, Riquelme I, Carrasco-Avino G,
Bizama C, Norero E, Owen GI, Roa JC and Corvalán AH:
MicroRNA-335-5p is a potential suppressor of metastasis and
invasion in gastric cancer. Clin Epigenetics. 9:1142017. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Wang J, Wang X, Liu F and Fu Y:
MicroRNA-335 inhibits colorectal cancer HCT116 cells growth and
epithelial-mesenchymal transition (EMT) process by targeting
Twist1. Pharmazie. 72:475–481. 2017.PubMed/NCBI
|
|
30
|
Tang H, Zhu J, Du W, Liu S, Zeng Y, Ding
Z, Zhang Y, Wang X, Liu Z and Huang J: CPNE1 is a target of
miR-335-5p and plays an important role in the pathogenesis of
non-small cell lung cancer. J Exp Clin Cancer Res. 37:1312018.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Yao L, Li M, Hu J, Wang W and Gao M:
miRNA-335-5p negatively regulates granulosa cell proliferation via
SGK3 in PCOS. Reproduction. 156:439–449. 2018.PubMed/NCBI
|
|
32
|
Cui N, Liu J, Xia H and Xu D: LncRNA
SNHG20 contributes to cell proliferation and invasion by
upregulating ZFX expression sponging miR-495-3p in gastric cancer.
J Cell Biochem. 120:3114–3123. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Lingling J, Xiangao J, Guiqing H, Jichan
S, Feifei S and Haiyan Z: SNHG20 knockdown suppresses
proliferation, migration and invasion, and promotes apoptosis in
non-small cell lung cancer through acting as a miR-154 sponge.
Biomed Pharmacother. 112:1086482019. View Article : Google Scholar : PubMed/NCBI
|
